Nykode Therapeutics Stock
Stocks
VACC
NO0010714785
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Oslo Bors
18:45:00 21/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.510 NOK | +10.00% |
|
+33.23% | +86.98% |
| 08-20 | Nykode Therapeutics Wins New US Patent for Neoantigen-based Cancer Vaccine | MT |
| 08-06 | Nykode Therapeutics Asa Announces Appointment of Jakob Helding Rasmussen as Chief Technology Officer | CI |
| Market Cap | 1.47B 158M 135M 126M 116M 217M 15.15B 220M 1.49B 583M 7.6B 594M 582M 24.96B | P/E 2026 * |
-6.98x | P/E 2027 * | -48.8x |
|---|---|---|---|---|---|
| Enterprise Value | 988M 106M 90.85M 84.55M 77.79M 145M 10.16B 148M 1B 391M 5.1B 399M 390M 16.74B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 5.54x |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Nykode Therapeutics
| 1 day | +10.00% | ||
| 1 week | +33.23% | ||
| Current month | +33.43% | ||
| 1 month | +45.02% | ||
| 3 months | +37.50% | ||
| 6 months | +26.40% | ||
| Current year | +86.98% |
| 1 week | 3.2 |  | 5.17 |
| 1 month | 3.04 | | 5.17 |
| Current year | 2.21 | | 5.17 |
| 1 year | 1.44 | | 5.17 |
| 3 years | 1.44 | | 30.18 |
| 5 years | 1.44 | | 85.3 |
| 10 years | 1.44 | | 93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Engsig
CEO | Chief Executive Officer | 54 | 01/01/2019 |
| President | 49 | 01/01/2017 | |
Harald Gurvin
DFI | Director of Finance/CFO | 51 | 03/05/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | - | |
Trygve Lauvdal
BRD | Director/Board Member | 57 | - |
Susanne Stuffers
CHM | Chairman | 45 | 23/04/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/03/25 | Buy | Company | 3,000,000 | 0.9187% | ||
| 20/12/24 | Buy | Director | 100,000 | 0.0306% | ||
| 20/12/24 | Sell | Director | 100,000 | 0.0306% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.00% | +33.23% | +158.16% | -83.07% | 158M | |
| -3.00% | +2.27% | +73.26% | +109.90% | 72.12B | |
| +1.90% | +23.53% | +59.48% | +94.82% | 65.85B | |
| +5.12% | +25.22% | +5.13% | -5.86% | 29.28B | |
| +0.55% | +1.64% | -4.63% | +480.92% | 27.47B | |
| +2.74% | +12.98% | +54.92% | +25.77% | 26.7B | |
| +0.47% | +6.12% | +37.01% | -15.31% | 20.06B | |
| +1.82% | -6.67% | +251.36% | +388.91% | 18.22B | |
| +0.94% | +3.36% | +15.30% | +548.19% | 16.4B | |
| +0.73% | +5.54% | +39.99% | +151.77% | 13.4B | |
| Average | +2.13% | +10.85% | +69.00% | +169.60% | 28.97B | |
| Weighted average by Cap. | +0.75% | +9.49% | +58.08% | +157.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 162M 17.38M 14.87M 13.84M 12.74M 23.8M 1.66B 24.21M 164M 64.07M 835M 65.27M 63.85M 2.74B |
| Net income | -208M -22.35M -19.12M -17.8M -16.38M -30.6M -2.14B -31.12M -211M -82.37M -1.07B -83.92M -82.09M -3.52B | -41.58M -4.47M -3.82M -3.56M -3.28M -6.12M -428M -6.22M -42.19M -16.47M -215M -16.78M -16.42M -705M |
| Net Debt | -485M -52.15M -44.62M -41.53M -38.21M -71.41M -4.99B -72.62M -492M -192M -2.5B -196M -192M -8.22B | -578M -62.09M -53.12M -49.44M -45.49M -85.01M -5.94B -86.46M -586M -229M -2.98B -233M -228M -9.79B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | NOK 4.510 | +10.00% | 6,809,048 |
| 20/08/26 | NOK 4.100 | -16.84% | 13,655,594 |
| 19/08/26 | NOK 4.930 | +52.40% | 13,117,907 |
| 18/08/26 | NOK 3.235 | -3.43% | 377,277 |
| 17/08/26 | NOK 3.350 | -1.03% | 955,408 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VACC Stock
Select your edition
All financial news and data tailored to specific country editions
